Tratamentul cancerului esofagian a devenit mai eficient datorită progreselor tehnicilor chirurgicale, abordării multidisciplinare, utilizării adecvate a terapiei neoadjuvante şi a îngrijirii perioperatorie în cadrul unor centre de excelenţă în chirurgia esofagiană. Esofagectomia este una dintre cele mai complicate şi exigente proceduri dintre toate intervenţiile chirurgicale gastro-intestinale cu o curbă foarte lungă de învăţare în care excelenţa se poate atinge doar prin perfecţionare de-a lungul întregii cariere chirurgicale. Rezultatele esofagectomiei sunt legate nu numai de volumul de cazuri operate ci şi de experienţa chirurgilor în managementul complicaţiilor postoperatorii. Iniţial, esofagectomia minim invazivă a întâmpinat obstacole în implementarea sa în mai multe centre datorită costurilor şi complexităţii tratamentulului cancerului esofagian. Mai multe metaanalize şi studii clinice publicate până în prezent susţin fezabilitatea abordului minim invaziv, avantajele procedurii din perioada imediat postoperatorie precum şi echivalenţa rezultatelor oncologice cu tehnica clasică, ceea ce constituie un pas important în impunerea tehnicilor minim invazive ca standard în tratamentul cancerului esofagian. În această lucrare, ne propunem să urmărim progresele recente în esofagectomia minim invazivă, evoluţia tehnicilor chirurgicale endoscopice prin prisma experienţei personale şi a rezultatelor studiilor publicate în literatura de specialitate în ultimii ani.
Introduction
Esophageal cancer (EC) is the eighth most common type of neoplasm diagnosed worldwide. Also, EC is the sixth most common cause of death by neoplasms with a 5-year survival rate of 20% because approximately 50% of patients are diagnosed at an advanced stage. In Europe, it is only the 19 th most common type of cancer, but the mortality rates associated with esophageal adenocarcinoma (which account for only 10% of all cases of oesophageal neoplasia globally), have exceeded in some regions those of esophageal squamous cell carcinoma. Distribution by sex is equal to squamous cell carcinoma and adenocarcinoma is three times more common in males than in women. The main risk factors for squamous cell cancer in Western countries are smoking and alcohol consumption, while adenocarcinoma occurs predominantly in patients with gastroesophageal reflux disease or with an increased body mass index (1) .
The treatment of esophageal cancer has become more effective through a multidisciplinary approach and the creation of centers of excellence with a large volume of esophageal pathology. Progress in staging, surgical technology, neoadjuvant therapy and perioperative care have reduced morbidity and mortality. The basic principle of curative treatment for the localized disease is surgery associated with neoadjuvant chemoradiotherapy for locally advanced stages.
Esophagectomy with locoregional lymphadenectomy is the standard treatment of patients with resected esophageal neoplasm and is associated with increased morbidity (40-50%), mortality (8-11%), low survival rate at 5 years of approximately 36% (even in experienced centers) and long postoperative recovery. Esophagectomy with esophageal reconstruction is a complex procedure requiring thoracic, abdominal or cervical approach and is recommended to be performed in centers with at least 20 cases operated per year (2) . Postoperative and long-term outcomes are influenced by several factors: patient selection, versatility in surgical procedure selection, standardized perioperative clinical care protocols, prompt intervention in the treatment of postoperative complications and multidisciplinary co-operation.
For invasive carcinoma, classical transthoracic esophagectomy (open esophagectomy-OE) is accepted as the best oncological operation because it allows complete tumor resection (R0), extended lymphadenectomy and restoration of digestive transit with intrathoracic or cervical anastomosis with a low rate of intraoperative complications. The pronounced systemic inflammatory response associated with significant trauma to thoracotomy and/or laparotomy determined the introduction of minimally invasive surgical techniques in the therapeutic arsenal.
Minimally invasive esophagectomy (MIE) has a relatively recent history, its introduction into practice is due in particular to the development of endoscopic surgery techniques. The first results reported in the medical literature appeared in 1992 when the first thoracoscopic esophagectomy was performed by Sir Alfred Cuschieri (3) . In the search for an ideal technique for esophagectomy were performed in the minimally invasive manner all types of approach practiced in open surgery, including assisted robotic (4) (5) (6) . MIE is a less traumatic procedure, allows for increased visualization of the operative field, simplification of postoperative care (blood transfusions, postoperative pain management), less incidence of postoperative complications, especially pulmonary infections, and postoperative DVT), shorter hospitalization and faster social reinsertion.
The minimally invasive approach requires mandatory experience in open esophageal surgery (which is difficult to obtain), advanced skills in endoscopic surgery, and the supervision of the first operations by an experienced mentor (7) . The duration of surgery, the morbidity and mortality associated with the procedure and the long learning curve (at least 35 operations) may initially be important obstacles in implementing the minimally invasive approach (8) .
Better recovery and faster social reinsertion may reduce the higher surgical costs of endoscopic surgical instruments, however, in order to reduce the duration of surgery, even in classic esophagectomy, mechanical devices are used to create faster the gastric conduit or to perform the intrathoracic anastomosis. Comparative studies in the literature did not report a difference in the real cost of MIE and had included postoperative complications, which are significantly associated factors of hospital costs also in open esophagectomy (9) .
The main techniques that have been imposed in current practice are: the threestage esophagectomy through the modified McKeown thoracoscopic, laparoscopic and cervical approach ((performed in left lateral position (Luketich, 1998) or in prone position (Cuschieri, 1994) ), two-stage esophagectomy by modified Ivor Lewis approach, laparoscopic and thoracoscopic (Watson, 1999) , transhiatal esophagectomy by modified Orringer (DePaula, 1995) approach, laparoscopic and cervical and robotic-assisted esophagectomy (Horgan, 2003) .
The MIE through the modified McKeown triple approach is the most commonly used worldwide since it provides a good visual field for mediastinal lymphadenectomy and by performing anastomosis at the cervical level avoids the complications associated with intrathoracic anastomotic leak (10) . Image magnification and pneumoperitoneum used in the laparoscopic transhiatal approach help to accurately identify dissection plans with a lower risk of lesion of the pleura, direct esophageal branches of the aorta or other structures adjacent to the esophagus (thoracic duct), thus reducing the risk of bleeding or the appearance of the chylothorax. The increase in the incidence of esophageal and esophageal junction adenocarcinoma in the western countries led to a more frequent use of two-stage MIE (laparoscopic and right thoracoscopic) with two-field lymphadenectomy followed by intrathoracic anastomosis in the upper mediastinum.
The prone position was used during the thoracoscopic esophagectomy and a much better exposure of the intrathoracic anatomical structures was obtained without fully collapsing the right lung and it can reduce the postoperative respiratory complications (11) . Compared to the standard left lateral position, a much better approach at the level of the right hemithorax is obtained, with less amplitude of movement of the mediastinum, the exposure is much better behind the right pulmonary hill with much easier visualization of the vascular elements , the lung is moved from the operative field of esophageal dissection even by its own weight, and the esophagus is not the most lower point of right hemythorax, and thus the blood resulting from the dissection is leaving the operative field (as opposed to the left lateral left decubitus in which the blood stagnates in the dissection area and its aspiration is required) (12) .
The thoracoscopic esophagectomy performed in the semi-prone position combines the advantages of left lateral left decubitus (allowing for rapid conversion) and prone position (better visualization and extended mediastinal lymphadenectomy) (13) .
Some limitations of MIE that include twodimensional view and the low degree of freedom of movement in the narrow field of the mediastinum have been eliminated by robotic surgery. The robotic platform has reduced the complexity of thoracoscopic and laparoscopic maneuvers using the endo-wrist robotic arm technology (7-degrees instrumental articulation). The enhanced 3D image at the highest resolution and the ability to perform fine movements allow performing of extensive mediastinal lymphadenectomy and a safe intrathoracic esophageal-gastric "hand-sewn" anastomosis. Reducing the learning curve (20 procedures) compared to the standard MIE also may increase the number of specialists who can acquire specific skills in a short period of time (14) .
Preoperative Clinical and Paraclinical Evaluation
Preoperative clinical and paraclinical evaluation includes, in addition to the clinical and endoscopic examination, a computerized tomography (thoracic and abdominal) for the local evaluation of the tumor process and the exclusion of the presence of hepatic or pulmonary metastases. Positron emission tomography (CT-PET) can prevent unnecessary surgery. However, peritumoral lymph nodes are often difficult to assess by PET due to the proximity of the primary tumor, and when the tumor is not completely stenotic, endoscopic ultrasound is useful in assessing the local lymph node extension.
Other additional investigations used are barium swallowing study that assesses esophageal tumor for palliation of dysphagia and hepatic ultrasound that is useful for detecting liver metastases. A bronchoscopy and an ENT exam are recommended for tumors located above the tracheal bifurcation or those in close contact with the left bronchus. In case of locally advanced esophageal distal adenocarcinoma (T3/T4) involving the esophagealgastric junction, a diagnostic laparoscopy is recommended to exclude peritoneal metastases, which may be present in approximately 15% of patients (15) . Tumor staging according to the AJCC/UICC classification (7 th or 8 th edition) with the histological type, the degree of anatomopathological differentiation and the location of the tumoral process influence the prognosis of patients with esophageal cancer (16, 17) . Medical evaluation, especially for patients who are scheduled for multimodal therapy and/or surgery should also include blood counts, liver, respiratory, cardiac and renal function tests. Long-term survival rates have improved by detecting esophageal cancer at a less advanced stage, adequate treatment during the perioperative period and using multimodal therapy. Neoadjuvant treatments including modern irradiation techniques with appropriate fractional doses reduced the side effects and associated postoperative mortality rates. In patients in early stages of disease (cT1-2N0), esophagectomy is recommended without a neoadjuvant treatment (18) . In stage IIb-III, neoadjuvant or adjuvant therapy is indicated because it increases resectability rate and long survival, and for stage IV, surgery only complements palliative treatment (19) . Neoadjuvant treatment modifies local anatomy, and difficulty may arise in thoracoscopic mediastinal dissection, therefore, detailed paraclinical reassessment is important after its completion, however minimal invasive esophagectomy performed after chemoradiation is considered safe (20) .
Patients with advanced neoplasm neoadjuvant treatment require additional nutritional support delivered by oral administration, naso-enteral tube or using a feeding tube due to low oral intake, dysphagia or odynophagia. Malnutrition is associated with increased operative risk, affect the quality of life of the patient, and is associated with low survival (21) . The use of a feeding tube is not recommended in all patients with esophageal cancer undergoing multimodal therapy and should avoid compromising future reconstruction options and all variants should be considered (stent vs gastrostomy vs. jejuno-stomy, open vs. endoscopic vs. laparoscopic). Endoscopic and laparoscopic approach benefit from a faster surgical recovery but are not free from complications (dislocations, obstructions of jejunostomies or small bowel obstruction) that may require surgical intervention in a patient who is undergoing neoadjuvant treatment. In endoscopic approaches, the risk of esophageal dilatation and perforation or metastasis at the insertion site of the feeding tube cannot be ignored (22) . From the clinical experience in the use of endoscopic percutaneous gastrostomy (PEG), we have not encountered further difficulties in preparing the gastric conduit.
Indications and Contraindications
MIE is indicated for the treatment of benign conditions requiring esophageal resection, such as post-caustic stenosis, scleroderma, dysmotilities or esophageal leiomyoma, as well as for patients with Barrett's esophagus (highgrade dysplasia) where endoscopic treatment has failed and there is a high risk of progression to adenocarcinoma. At the introduction of MIE in the treatment of oesophageal cancer, indications for the minimally invasive approach were early stages or tumors with a good response after neoadjuvant treatment. Nowadays, MIE indications for treatment of esophageal cancer are similar to those in open surgery and depend on tumor location, staging, the clinical status of the patient and comorbidities or preference of the surgical team. In patients with a history of thoracic surgery, thoracoscopic esophagectomy is contraindicated because, in the case of modified anatomy or adhesion, dissection would prolong the duration of the intervention and increase the risk of lung injury. Also, bulky tumors and locally advanced infiltrating tumors (T4), especially those in contact with the airway, are a relative contraindication to the thoracoscopic approach. Relative contraindications of laparoscopy include previous surgery on the upper abdomen.
Pre-operative Assessment
Pre-operative blood count, coagulation, renal and hepatic function are assessed and electrocardiogram, cardiac ultrasound, chest x-ray and pulmonary function tests are performed. Preoperative preparation of the patients involves low molecular weight heparin (LMWH), respiratory exercises and mechanical bowel preparation for eventual reconstruction with colon in case of an inappropriate gastric conduit.
Endoscopic surgical developments have supported MIE and have resulted in better clinical outcomes through safe intraoperative hemostasis, shortening operative times and performing quality anastomoses. The 3D highdefinition three-dimensional thoracoscopic image (using the 3D HD standard, 3D video scope Endoeye Flex with 100 degrees of articulation or 3D robotic) and 4K Ultra HD improves depth perception and allows for more accurate lymphadenectomy and faster anastomosis compared to 2D (23, 24) . The single-port technique used in some centers does not compromise the extent of surgical resection or postoperative outcomes (25) .
At the Center of Excellence in Esophageal Surgery at St. Mary's Hospital in Bucharest, we introduced the MIE through the modified McKeown triple approach to reduce the pulmonary complications rate. Based on the experience of the first cases, we have found that careful pre-operative selection of cases is important in order to have a higher probability of resectability without conversion to open surgery and to avoid accidents during thoracoscopy.
The surgical instruments used in the clinic for MIE usually contains the standard 3D HD laparoscopic surgery kit, trocars Thoracoport 11.5 mm for thoracoscopic approach, EndoGIA Universal Roticulator Stapler 3.0-2.0 mm with vascular cartridge white, gray or violet (Tri-Staple™ technology), Hem-o-lok™ system endoscopic vascular seal, Ligasure Endoscopic 5 mm, Sonicision™ Ultrasonic 5 mm, a linear stapler GIA 45-60 mm with blue or green cartridge, Penrose tube for esophagus isolation during thoracoscopy and an endoscopic retractor (EndoFan).
Thoracoscopic Stage
Antibiotic prophylaxis is used, an arterial line is inserted for monitoring the blood pressure and a central venous line is required. After the selective orotracheal intubation using the Carlens tube, for the thoracoscopic approach we used the left lateral position. The surgeon is located on the right side of the patient and the assistant and cameraman on the left side. Five work trocars are used as follows: a 10 mm optical trocar in the 8 th intercostal space anterior to the middle axillary line, three 10 mm working trocars (in the the 9 th intercostal space, behind the posterior axillary line, in the 7 th intercostal space, anterior of the anterior axillary line, in the 4 th intercostal space, on the anterior axillary line for the EndoFan) and a 5 mm working trocar anterior and inferior to the tip of the shoulder blade ( Fig. 1) .
After installing trocars, the lung is collapsing and the right hemothorax is explored. CO2 insufflation up to a pressure of 8 mmHg can be used to collapse the lung. The first step is the incision of the pulmonary triangular ligament at the level of the inferior pulmonary vein that can be done with the Hook or Ligasure. This is followed by incision of the mediastinal pleura inferior and superior to the azygos vein. A 10 mm EndoFan is used to retract the lung. The azygos vein is dissected and carefully isolated and then cut after is stapled with an EndoGIA Ultra vascular with a 3.5 mm or 45 mm white or gray cartridge depending on its size (Fig. 2) . Continuing with the dissection of the thoracic esophagus and its isolation with a Penrose tube, at which time mediastinal lymphadenectomy is also practiced with the ultrasonic dissector or the Ligasure from the upper thoracic aperture to the distal esophagus (Fig. 3, Fig. 4) . A safe hemostasis is performed using endoscopic clips for posterior aortic-esophageal vessels to prevent postoperative hemorrhage or chylo- Pleural drainage is placed in the apex and at the base of the thorax adapted to a Béclaire closed drainage system, the lung is expanded under visual control, the trocars are extracted and the chest wounds are sutured. For resection and extended lymphadenectomy, it was proposed to use virtual reality and sentinel ganglion detection that would allow exact localization of tumor and adjacent lymph node stations in real time, but to date, there is insufficient evidence to support the routine use of these techniques (27, 28) . To prevent unilateral or bilateral recurrent nerve damage during extended lymphatic dissection (34-67% incidence), continuous intraoperative monitoring was used (commonly used in thyroid surgery), but studies conducted to date did not report statistically significant differences in post-operative outcomes (29) .
Laparoscopic Stage
Laparoscopic mobilization of the stomach is an important contribution to esophageal cancer surgery because it reduces the trauma of two-cavity operation to the patient and allows for the construction of a gastric graft comparable to that prepared by the open approach (30) . The patient is placed in the French laparoscopic supine position, the Carlens selective orotracheal intubation tube is changed to one with a single lumen. Laparoscopic trocar position is described as follows: a 10 mm supraumbilical optical trocar on the umbilical line, three 10 mm work trocars (subxiphoid for EndoFan, supraumbilical lateral to the right medial-clavicle line, supraumbilical lateral to the left medialclavicle line) and a 5 mm trocar in the left upper quadrant used by instruments for traction and contraction (Fig. 7) . After the creation of pneumoperitoneum, the optic trocar is introduced and the abdominal cavity is explored. The patient is placed in the Fowler position. The EndoFan is inserted into the subxiphoid trocar and helps to retract the left hepatic lobe from the work field and exposure of the esophageal-gastric junction. The vascular arch of the stomach is assessed. The gastrocolic ligament is divided in the middle and the dissection is continued to the left to the gastrosplenic and gastrophrenic ligament using the Ligasure or endoscopic clips (Fig. 8) .
To prevent possible detachment of clips during mediastinal pull-up is important to avoid using endoscopic clips on short gastric vessels. The gastric conduit is prepared by following the preservation as the source of vascularization of the right gastroepiploic artery. Celiac lymphadenectomy is facilitated by upper traction of the stomach using the EndoFan. The hepatogastric ligament is sectioned, the omental pouch is opened and the adhesions of the posterior aspect of the stomach are dissected. The esophageal junction and the abdominal esophagus are dissected with the partial diaphragmatic crus sectioning to allow the conduit to ascend. Laparoscopic gastric mobilization is performed by cutting the left gastric pedicle with a vascular stapler and lymphadenectomy in the celiac plexus is completed (Fig. 9) . The stomach is the preferred organ in esophageal reconstruction due to good vascular supply, it is long enough to avoid tension in anastomosis and is easy to prepare by the laparoscopic approach and for restoring digestive continuity is requiring a single anastomosis. However, if the stomach cannot be used, a colonic interposition can be performed. Interposition of the right colon to restore gastrointestinal continuity was performed by Nguyen et al. with good results through the minimally invasive approach (31) . There are wide variations in the methodology used in the preparation of the gastric conduit. Some authors support the use of the entire stomach to keep collateral blood in the anastomosis in an effort to minimize the risk of complications of ischemia and anastomotic leak. Other authors support the use of a tubular stomach to optimize the length of the graft and its function after advancing in the chest or cervical. Luketich et al. reported an increase in the incidence of gastric necrosis and anastomotic fistula when using a narrower gastric tube (3-4 cm in diameter); but by increasing the diameter of the gastric conduit to 5-6 cm, a decrease in anastomotic complications was observed (32) .
Partial laparoscopic gastric devascularization performed before MIE has been proposed to improve stomach microcirculation by stimulating neovascularization. This is a safe technique and does not interfere with subsequent reconstruction, but it has not become a routine technique in esophagectomy. Schroder et al. performed a comparative retrospective study in 238 patients who had partial laparoscopic gastric ischemic devascularization by full stomach mobilization compared to 181 patients who had esophagectomy without devascularization but did not find any differences statistically significant in the incidence of anastomotic fistula (9.4% vs. 7.6%) (33) .
The objective evaluation of vascular changes during its preparation was also proposed to assist in choosing the optimal area for anastomosis and to eliminate the risk of ischemia. Traditionally, the evaluation of the viability of the gastric conduit is made by visual inspection of its color and by monitoring of the quality of bleeding the anastomosis site or the palpation of the arterial pedicle. Proper identification of vascular supply for the gastric conduit can be difficult during laparoscopic approach. Several methods of analysis blood perfusion of gastric conduit were used, including spectophotometry, CT angiography, Doppler ultrasound, intramuscular gastric pH measurement, but no significant reduction in anastomotic fistula was observed.
Recently introduced in the intraoperative real-time evaluation of gastric conduit perfusion, infrared angiography with indocyanine green (NIFA) is particularly useful during the learning curve to prevent intraoperative complications and avoid unintentional trauma. NIFA identifies gastric vascular supply with greater certainty and helps in the preparation of the gastric conduit, in choosing the optimal anastomosis site based on the vascular model and can be considered an important step in optimizing surgical technique and in reducing postoperative morbidity and mortality. Used by Zehetner et al. in 150 consecutive patients, a good infusion of the graft was found in 44% of the patients while the other patients had a demarcation line between the rapid infusion area and the slower perfusion of the fundus of the stomach. The rate of anastomotic fistula was significantly lower in patients where anastomosis was performed in the optimal perfusion area (2% vs. 45%, P <0.0001) (34) . The use of infrared imaging during minimally invasive esophagectomy may also be useful for detecting lymph node metastasis located in the proximity of the tumor and to guide lymphadenectomy extension or for evaluation of tumor margins (35) .
Left Cervical Approach
A left cervical incision of 4 to 6 cm is practiced at the anterior margin of the sternocleidomastoid muscle. The dissection, isolation, and section the cervical esophagus is performed (Fig. 10) . The distal extremity is closed and it is anchored to a Levine nasogastric tube, then esophagectomy specimen is extracted through a supraumbilical minilaparotomy. In the transition from open surgery to MIE, we have prepared the extracorporeal gastric conduit to prevent complications associated with this operative step.
Extracorporeal preparation of the conduit can be done using the Akiyama technique with creation of gastric conduit (at a width of 5-6 cm) by resection of the small gastric curvature using a GIA linear stapler with green or blue cartridge and strengthening of the mechanical suture with Vicryl 3-0 or PDS 3-0 or using the Nakayama technique with section of the gastric conduit at the level of cardia (Fig. 11) . MIE with the extracorporeal preparation of the gastric graft reduces the risks associated with the learning curve and has a positive impact on postoperative outcomes (36) .
The association of delayed evacuation of the vagotomized gastric conduit after esophagectomy with the occurrence of anastomotic fistula determined the inclusion in the operative technique of extramucosal pyloromyotomy or Heinecke-Mikulicz pyloroplasty by laparoscopic approach. Pyloroplasty prolongs the duration of surgery and has its own risks and is not routinely indicated. Some studies have also found that there is no difference in the longterm functional outcome of delayed gastric evacuation (37) . Many centers use chemical pyloroplasty by injecting intrapiloric botulinum toxin as prophylaxis against delayed gastric emptying, but the effects are temporary and the technique is not routinely used, and some authors find it is unnecessary in minimally invasive esophagectomy (38) . Delayed gastric emptying after esophagectomy with gastric reconstruction can be treated with endoscopic pneumatic dilations with very good functional results (39) . On the other hand, long-term survival of patients with esophageal neoplasm revealed the occurrence of major biliary reflux and reflux oesophagitis, particularly in patients with MIE and intrathoracic anastomosis and pyloroplasty (40) .
After preparation, the gastric conduit is attached to the Levine tube and is ascended cervical through the posterior mediastinum using the pull-up gastric technique and the end-to-side cervical esophageal-gastric anastomosis is performed with interrupted suture (3-0 PDS, 4-0 Silk) or continuous suture (4-0 Maxon). A 14Ch nasogastric tube is placed for postoperative drainage of the gastric conduit. A feeding jejunostomy is inserted for early enteral nutrition postoperatively. Feeding jejunostomies are routinely placed through the minimally invasive approach using Stamm, Witzel or Seldinger modified technique and are associated with low but not insignificant morbidity (41) .
We prefer the triple approach to avoid intrathoracic anastomosis that may be complicated in the case of a mediastinal leak with the occurrence of mediastinitis and significant postoperative mortality. The experience accumulated over several decades in the hand-sewn or stapled manner of cervical anastomosis in open esophagectomy did not significantly reduce the fistula rate or anastomotic stenosis, despite it was performed end-toside or side-to-side (42) . Stapled anastomosis reduces the duration of surgery and the incidence of postoperative anastomotic stenosis (43) . In the case of anastomotic fistula, it can be treated conservatively by opening the cervical wound, and in the case of anastomotic stenosis, the endoscopic dilations can be performed. Also, cervical anastomosis has been associated with significant problems of swallowing and tracheobronchial aspiration which may increase the risk of pulmonary complications and can affect the general status of the patient (44) . Compared to cervical anastomosis, intrathoracic anastomosis can reduce anastomotic tension and reduce ischemia of gastric conduit and the incidence of anastomotic leaks or stenoses requiring endoscopic dilation. Also, the intrathoracic anastomosis was associated with better functional results with a lower incidence of dysphagia and recurrent nerve injury (45). Nowadays, several centers have stopped using the triple approach (including open or hybrid surgery) and they propose an intrathoracic anastomosis in the upper mediastinum by two-stage Ivory Lewis's laparoscopic and thoracoscopic approach to avoid cervical approach, while respecting oncological safety margins performing frozen sections histopathological examinations intraoperatively (46) .
At the beginning of the use of the minimally invasive approach in the treatment of esophageal cancer, circular stapler devices were used to perform an end-to-side esophagealgastric anastomosis with the transoral insertion of the ORVIL (47). Subsequently, it was proposed to perform a wide side-to-side anastomosis (6 cm) to prevent stenosis (48) . The introduction of robotic surgery has proposed the "hand-sewn" intrathoracic anastomosis, using the V-Loc ™ self-locking suture, yet it is considered technically demanding and therefore is not frequently used (49) .
The laparoscopic preparation of an omental patch with blood supply from gastric large curve (a variant of the technique described by Goldsmith in 1968) was proposed to prevent an intrathoracic anastomotic leak. This is a useful technique because of its ability to induce neovascularization in the avascular areas, increasing the collateral blood supply (50) . Currently, it is selectively used, most frequently in patients who have received neoadjuvant radiotherapy because it prolongs the surgery (51) . Intraoperatively, the use of vasoconstrictors is avoided, a maximum of 2L of intravenous solutions is administered, and a warm air blanket is used to maintain an intraoperative normal temperature. Drainage of the peritoneal cavity is routinely used.
Intraoperative Incidents
Among the most important incidents or accidents that may occur during thoracoscopy are the following: the introduction of the first trocar intraabdominal with possible liver damage, injury of large intrathoracic vessels, azygos vein, tracheal membrane, lung parenchyma or recurrent laryngeal nerve; they may in some cases cause conversion to open surgery. The average conversion rate reported in the literature is 5-7% depending on the used technique (52) .
Also, during the dissection of the esophagus, pulmonary parenchyma can be traumatized and the injuries may take the form of a contusion (which can be treated conservatively) or even cause rupture of the pulmonary parenchyma that may require its suture or resection. Communication between surgical and anesthesia team is very important to prevent these incidents. The thoracoscopic mediastinal dissection may be technically difficult due to anatomical, clinical-pathological factors (tumor stage) or post-chemoradiation adhesions. Some studies have identified the mediastinal adiposity, the position of the spine in relation to the esophagus, or the size of the upper thoracic aperture as anatomic factors that may influence intraoperative blood loss or the duration of surgery (53, 54) .
The injury of the thoracic duct is very rare and usually, is not recognized intraoperatively. During laparoscopy, the most common incidents are related to the mobilization of the stomach (injury of the gastro-epiploic right pedicle, the spline, the left liver lobe, or hemorrhage from the left gastric artery or short gastric vessels). These incidents are frequent during the learning curve of MIE and may affect the integrity of the gastric conduit in the immediate postoperative period. The Chirurgia, 113 (1), 2018 www.revistachirurgia.rometiculous attention during the laparoscopic preparation of the graft, the evaluation of venous drainage, the optimal dimensioning of the hiatus, the avoidance of tension in the gastric conduit, or the extracorporeal preparation are important factors in the prevention of its ischemia (55) .
Postoperative Period
The duration of the operation is approximately 300 minutes, including the repositioning time of the patient. Patients are usually extubated in the operating theatre and transferred to the intensive care unit or high dependency unit. Early extubation may reduce the duration of admission to the intensive care unit (56) . If the surgery was carried out without incidents and the patient had no cardiac-pulmonary comorbidities, it is extubated immediately after surgery. A chest X-ray is performed to assess the position of the drainage tubes after pulmonary expansion.
A standard postoperative clinical protocol for esophagectomy is used. High epidural anesthesia has clear benefits in relieving postoperative pain, facilitating faster extubation and early mobilization, thus reducing respiratory complications and duration of hospitalization. Respiratory physiotherapy is initiated and the feeding is started on the jejunostomy on the first day after surgery. Nasogastric drainage of the gastric conduit is maintained in the first postoperative days. Early mobilization of patients prevents lung complications, influences muscle strength, anxiety and quality of life of the patient (57) . Hemo-dynamic monitoring and blood oximetry are very important after esophagectomy. Restriction of intravenous fluids according GDFT (gold directed fluid therapy) has positive effects on respiratory function. Administration of vasopressors should be avoided because they can reduce blood flow to the stomach conduit (58) . Gastrointestinal, renal, neurological function are monitored and infectious risk is assessed by measuring the temperature, repeating the blood count, CRP and procalcitonin. Changes in post-operative consciousness in the absence of risk factors (age, associated pathology) may be the consequence of postoperative medical or surgical complications (59) . The appearance of pleural drainage in the first days postoperatively may indicate the occurrence of the leak anastomotic, and the amount (approximately 100-400 ml/day) expresses the functionality and also may show the presence of an air leakage. Radiological exam with iodine contrast agent is performed 5-7 days postoperatively, after which the oral feeding is gradually resumed and the Béclaire pleural drainage is suppressed.
Nowadays, there is no consensus on the optimal resumption of oral nutrition which is postoperatively replaced by enteral nutrition. Early postoperative oral nutrition recommended by nutrition guidelines may increase the incidence of lung or anastomotic fistulae due to the risk of tracheobronchial aspiration associated with esophagectomy (60) . Starting an oral diet after esophageal surgery can improve postoperative recovery and quality of life, reducing discomfort in the use of the feeding jejunostomy. The patient is usually discharged in the second postoperative week if there are no septic or leak complications.
The follow up at 3 weeks postoperatively involves a clinical examination, assessment of nutritional status, pulmonary x-ray, esophagealgastric barium swallow, upper gastrointestinal endoscopy and feeding jejunostomy is removed. The oncological follow up determines whether adjuvant chemotherapy is required depending on the final histopathological result, then the patients are re-evaluated at 6 months, 12 months, 24 months, 3 years and 5 years, or anytime if a postoperative complication occurs.
Postoperative Complications
Esophagus surgery involves extensive mediastinal dissection, a trauma of lung and peribronchus nerve structures and there is an increased risk of inoculation of a sterile area with bacteria from digestive cavities, conditions that may cause a generalized inflammatory syndrome (SIRS). The Clavien-Dindo classification is used to evaluate postoperative complications (61) . Complications in the immediate postoperative period after esophagectomy (air leak, volvulus or gastric necrosis, thoracic duct injury, bilateral laryngeal recurrent nerve paralysis) may in some cases require emergency reoperation. Reintervention may be thoracoscopic/ thoracotomy, as appropriate, for graft excision, thoracic duct ligation at the hiatus, sealing of an air leak or other surgical procedures (cervical esophagostomy, tracheostomy).
Also, respiratory, cardiac and anastomosis leaks may influence the prognosis of patients requiring admission in the intensive care unit. Pulmonary complications are common after esophagectomy (30-60%), approximately 80% are early complications and occur within the first five days postoperatively (atelectasis, bacterial pneumonia, and adult respiratory distress syndrome-ARDS). Using the minimally invasive approach has reduced the incidence of lung complications by reducing pulmonary parenchyma manipulation by using atraumatic instruments in the mediastinal dissection. Neoadjuvant treatments have not been associated with a significant increase in the risk of lung complications (62) .
Intrathoracic anastomotic leak causes a strong systemic inflammatory response with severe mediastinitis, pleural empyema or sepsis difficult to treat. The incidence of intrathoracic anastomotic fistula reported in the literature ranges from 1% to 10% and was associated with a high postoperative mortality of approximately 60% if leak drainage is inadequate or if there is an important anastomotic defect. Reintervention for repositioning of drainage tubes or restoration of the anastomosis is associated with high mortality rates (20-32%). Endoscopic interventions (endoscopic clips, bioadhesive injection or implantation of covered self-expandable stents, endoscopic vacuum therapy (E-VAC using an EndoSponge) are an alternative for treatment (63, 64) . Approximation with endoscopic clips is difficult in case of a large anastomotic defect and the injection of fibrin adhesive is associated with a risk of thrombosis or embolization (65, 66) . The endoscopic insertion of covered stents has a success rate of over 80%, but is not without complications (stent migration, difficulty in removing the stent due to the growth of tissues and the development of anastomotic stenosis (27.5%), which can be dilated endoscopically) (67, 68) .
Cervical anastomotic leak benefits from conservative treatment with very good results. Drainage of the fistula through the cervical wound reduces the risk of sepsis, and the association of the enteral nutrition through the alimentary jejunostomy decreases the risk of postoperative mortality. The occurrence of anastomotic fistula is determined by certain specific risk factors for esophageal cancer and cervical anastomosis: malnutrition, neoadjuvant therapy, ischemia and atherosclerosis of the gastric conduit supply arteries, anastomosis technique, anastomosis tension, number of esophagectomy/year or the size of the upper thoracic aperture (69) (70) (71) (72) .
Long-term postoperative complications (delayed discharge of the gastric graft and hiatus hernia) are the result of the technical procedure. The use of prokinetic agents (Metoclopramide, Motilium, Erythromycin), pneumatic dilatation, or pyloric botulinum toxin injection are alternative treatments prior to a pyloroplasty (13) . A hiatus hernia has an increased incidence after minimally invasive approach (7-9%) compared to open esophagectomy possibly due to the reduction in postoperative adhesion formation and is becoming more relevant due to the increase in survival rate (74) . The laparoscopic approach can be used to treat a hernia and the use of a mesh should avoid the risk of vascular injury of the gastric conduit (75) .
Mediastinal dissection increases the risk of cardiac arrhythmias (3-18%) that may cause hemodynamic instability and increased postesophagectomy morbidity, regardless of whether a minimally invasive or open approach is used (76) .
Discussions
With a 25-year history of continuous development and refinement, the minimally invasive approach has been widespread throughout the world and is increasingly being used in the treatment of resected oesophageal cancer (77) .
The first results of minimally invasive surgery for esophageal cancer found a much better control of postoperative pain, less recovery and fewer lung complications or infections of the wounds. These were followed by the criticism of those who performed minimally invasive esophagectomy, but with disappointing results (conversion rate of 10-17%, pulmonary complications between 17% and 42% or mortality 3-12%) that were not very different from those of open surgery (78) .
A large number of meta-analyses or retrospective studies reported contradictory results of using of minimally invasive esophagectomy. Comparative studies between MIE and classical esophagectomy showed a similar duration of surgery, decreased intraoperative blood loss, a lower rate of lung complications, recurrent laryngeal nerve injury in fewer cases, a shorter duration of admission to the intensive care unit and the shorter period of hospitalization. Comparative studies supported the feasibility of the minimally invasive approach, with its advantages in the immediate postoperative period and similar results in terms of the mediastinal lymph node resection rate.
However, there are controversies about using the minimally invasive approach in practice because it requires a demanding and difficult technical support, is a laborious operative technique and has a long learning curve. The results of the minimally invasive approach are related to the activity of clinics that perform this surgery, the surgeons experience in minimally invasive thoracoscopic and laparoscopic surgery and the involvement of the intensive care team in the management of specific postoperative complications of this surgery. The equivalent results between the open and the minimally invasive approaches have not sufficiently motivated some centers to use the minimally invasive approach and were reluctant to change the standardized standard techniques used with good results for the treatment of esophageal cancer.
The first large series of minimally invasive esophagectomy with over 1,000 patients was published by Luketich et al. who reported results comparable to open technique in terms of oncology resectability (79) . In the multicenter study conducted in collaboration with the Eastern Cooperative Oncology Group (2015), Luketich et al. found favorable immediate postoperative results of MIE with an incidence of ARDS of 5.7%, pneumonia of 3.8%, and of atrial fibrillation of 2.9%, an average of 19 resected lymph nodes, negative margins (R0 resections) in 96% of patients, an average hospitalization duration of 2 days, a mean hospitalization of 9 days, an anastomotic leak rate of 8.6% and a mortality rate of 2%. The 3-year survival rate was 58.4% and was similar to that of the patients who received open esophagectomy and the locoregional recurrence was 6.7% (80) .
In centers with experience in the minimally invasive approach to esophageal cancer who are currently using standardized surgical treatment protocols, the technical limits of minimally invasive esophagectomy has not been reached yet, as it still benefits from improvements, but we can state that postoperative results are in greatly influenced by the postoperative evolution specific to oesophageal pathology and resection and less by the operation itself and there are good arguments for using this approach.
The prone position, already used in many centers, for its ergonomic advantages and excellent operator field exposure, was associated with a shorter operator time compared to the left lateral decubitus (86 minutes vs. 123 minutes, Fabian et al.) and fewer lung complications (6%) (81) .
The robotic technique has also reduced MIE limits while preserving its advantages over open esophagectomy, the technically difficult steps of MIE with long learning curves such as pyloroplasty and thoracoscopic mechanical anastomosis are much easier performed. Mediastinal dissection, especially in patients with neoadjuvant therapy or those with locally advanced tumors, may be facilitated by superior optics and visualization provided by RAMIE. The simplification of operative performance and the potential reduction of chronic trauma and injury related to the use of endoscopic instruments, involving in particular long and complex operations, can be significant benefits for the surgical team (82 (83) . The cost of the equipment, the learning curve, the extended robot setting time and the instrument engineering limits are obstacles to use in more specialized centers. Van der Sluis et al.
(2015) evaluated long-term oncology results of RAMIE with lymphadenectomy on two abdominal and thoracic fields and found that RAMIE is oncologically effective with a low percentage of local recurrence (6%) and 42 % overall 5-year survival) (84) .
The first randomized multicenter study (TIME trial), which included 115 patients and compared thoracoscopic esophagectomy in prone position and laparoscopic preparation of the gastric conduit with standard posterolateral thoracotomy and laparotomy (OE) followed by intrathoracic or cervical anastomosis reported the obvious short-term advantages of the MIE techniques in the first 2 weeks postoperatively (9% MIE vs. 29% OE, P = 0.005), less blood loss intraoperatively, a reduction in the incidence of postoperative pain, a shorter hospital stay (11 MIE vs 14 days OE, P = 0.044), recurrent laryngeal nerve palsy in fewer patients (2% MIE vs 14% OE, P = 0.012) and improvement of postoperative quality of life. The conversion rate to open esophagectomy recorded in this trial was 14%. The rate of R0 resection, the number of dissected lymph nodes (20 MIE vs. 21 OE) and the rate of anastomotic fistula (7% OE vs. 12% MIE, P = 0.390) and mortality (1.8% OE versus 3.4% MIE) were not significantly different (85) . The study found a better quality of life in the first year after surgery and especially in the first 6 weeks postoperatively for patients who benefited from the minimally invasive approach compared to open esophagectomy (86) . Patients experienced postoperatively a slow progressive improvement in physical activity that lasted 18-24 months until it reached a level comparable to preoperative level. Swallowing and nutrition problems required 18-24 months for readaptation, while dysphagia occurred in the immediate postoperative period, declining in intensity after 6-9 months and continued to improve at 18 months postoperative. A postoperative cough was present in the first 9 months, then with a reduction in intensity but without definitive disappearance at 24 months. Three-year outcomes (2017) showed no difference in survival without recurrence (37 (ROBOT trial) found equivalence between the two techniques in terms of short-term oncogene results. It also resulted in a lower percentage of postoperative complications, decrease in intraoperative blood loss and reduction of hospital admission and a better postoperative life quality compared to classical esophagectomy (90) .
In a comparative analysis of postoperative quality of life after minimally invasive esophagectomy, Parameswaran et al. reported less asthenia at 3 months postoperatively and lower intensity of pain associated with gastrointestinal symptoms compared to open esophagectomy (91) . In a retrospective evaluation of postoperative symptoms performed by Mehran et al. there was no difference in the functional results of the two approaches (92). Sundaram et al. have established that there are no significant differences in terms of quality of life parameters 12 months after surgery between MIE and open esophagectomy (93) .
The continuing evolution of endoscopic techniques will support the improvement of MIE with much better postoperative outcomes than at present. Also, familiarizing young surgeons with minimally invasive techniques will further promote and enhance the use of MIE to become the first therapeutic option in any esophageal surgery center for early-stage cancer and tumors with good chemoradiation response.
We support the laparoscopic mobilization of the stomach to prepare the gastric conduit and also extracorporeal preparation for the surgeons who are in the learning curve. Also, assessing the vascularization with angiography with indocyanine green laser should become a routine. The intermediate position of the semi-prone position may be used for thoracoscopic esophagectomy to accommodate the different anatomical image in the transition from the lateral decubitus to the prone position. An anastomosis in the superior mediastinum that respects the oncology safety margins can avoid the complications of the cervical anastomosis. Pyloroplasty is not absolutely necessary and we do not recommend doing it routinely. The early resumption of enteral nutrition on the alimentation jejunostomy is used in many centers without significant complications (intolerance, hydro-electrolytic imbalance). The hybrid esophagectomy used with very good results compared to open esophagectomy is an important step in the implementation of minimally invasive techniques at the global level. Supported by the latest published results, we believe that it is time for minimally invasive esophagectomy to become the standard treatment recommendation for oesophageal cancer. Robotic-assisted esophagectomy will probably represent the future of resectable esophageal cancer.
Conclusions
Current treatment of esophageal cancer involves multidisciplinary cooperation. The surgical approach of the esophagus is difficult and reserved for centers specialized in esophageal pathology because it is associated with considerable morbidity and mortality and a long-term postoperative recovery.
Minimally invasive esophagectomy is a less traumatic surgical procedure with an easier postoperative recovery. MIE allows the simplification of postoperative care, the reduction of the incidence of postoperative complications, especially pulmonary, the decrease of the hospital stay and a faster social reintegration.
Comparative studies published up to date in the literature have shown oncological results similar to classical esophagectomy. However, the minimally invasive esophagectomy has a long learning curve, requires extensive experience in open esophageal surgery, but the robotic approach increasingly used to provide solutions to overcome this obstacle. Also, the technique is associated with high cost of surgical instruments, however, surgeons should choose an surgical approach based on clinical factors, rather than cost implications.
MIE is a safe technique that has already passed the test of time and, together with hybrid esophagectomy, should be the standard approach to the surgical treatment of esophageal cancer in centers of excellence in esophageal surgery.
